are glp 1 injectable List of approved and pending GLP-1 medications GLP-1/ Weight Loss Injections -

Clin J Am Soc Nephrol 2021;16:384-95.PubMedPMC 62

Over the last decade, pharmaceutical manufacturers have been producing improved versions of GLP-1 drugs to treat diabetes, obesity and most recently cardiovascular disease, marketed as Ozempic and Wegovy, among others

Vials can cost anywhere from $100 to $400 or more depending on the concentration, pharmacy, and formulation

Ultomiris (ravulizumab-cwvz) Indication(s): Multiple rare, complement-mediated disorders, including paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), neuromyelitis optica spectrum disorder (NMOSD) Manufacturer(s): Alexion/AstraZeneca 2024 Sales: $3.92 billion Why it sold so well: Ultomiris, developed by Alexion, AstraZeneca Rare Disease, is emerging as a hematology drug to watch in 2025, driven by strong commercial momentum and expanding clinical uptake in 2024

Gastrointestinal (GI) adverse eventsparticularly nausea, vomiting, diarrhea, and constipationare the most common side effects, generally emerging during dose escalation and resolving over time